Eintrag weiter verarbeiten
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of...
Gespeichert in:
| Zeitschriftentitel: | Molecular Nutrition & Food Research |
|---|---|
| Personen und Körperschaften: | , , , , |
| In: | Molecular Nutrition & Food Research, 54, 2010, 9, S. 1371-1380 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Jain, Sushil K. Croad, Jennifer L. Velusamy, Thirunavukkarasu Rains, Justin L. Bull, Rebeca Jain, Sushil K. Croad, Jennifer L. Velusamy, Thirunavukkarasu Rains, Justin L. Bull, Rebeca |
|---|---|
| author |
Jain, Sushil K. Croad, Jennifer L. Velusamy, Thirunavukkarasu Rains, Justin L. Bull, Rebeca |
| spellingShingle |
Jain, Sushil K. Croad, Jennifer L. Velusamy, Thirunavukkarasu Rains, Justin L. Bull, Rebeca Molecular Nutrition & Food Research Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats Food Science Biotechnology |
| author_sort |
jain, sushil k. |
| spelling |
Jain, Sushil K. Croad, Jennifer L. Velusamy, Thirunavukkarasu Rains, Justin L. Bull, Rebeca 1613-4125 1613-4133 Wiley Food Science Biotechnology http://dx.doi.org/10.1002/mnfr.200900177 <jats:title>Abstract</jats:title><jats:p>Chromium and cysteine supplementation can improve glucose metabolism in animal studies. This study examined the hypothesis that a cysteinate complex of chromium is significantly beneficial than either of them in lowering blood glucose and vascular inflammation markers in Zucker diabetic fatty (ZDF) rats. Starting at the age of 6 wk, ZDF rats were supplemented orally (daily gavages for 8 more weeks) with saline‐placebo (D) or chromium (400 μg Cr/Kg body weight) as chromium dinicocysteinate (CDNC), chromium dinicotinate (CDN) or chromium picolinate (CP) or equimolar <jats:sc>L</jats:sc>‐cysteine (LC, img/Kg body weight), and fed Purina 5008 diet for 8 wk. ZDF rats of 6 wk age before any supplementations and onset of diabetes were considered as baseline. D rats showed elevated levels of fasting blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and oxidative stress (lipid peroxidation) and lower adiponectin and vitamin C, when compared with baseline rats. In comparison to D group, CDNC group had significantly lower blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and lipid peroxidation and increased vitamin C and adiponectin levels. CDN, CP or LC showed significantly less or no effect on these biomarkers. Only CDNC lowered blood creatinine levels in comparison to D. While CDN and CP had no effect, activation of NFκB, Akt and glucose transporter‐2 levels were decreased, insulin receptor substrate 1 (IRS‐1) activation increased in livers of CDNC‐rats. CDNC effect on glycemia, NFκB, Akt and IRS‐1 in liver was significantly greater compared with LC. Blood chromium levels did not differ between Cr‐groups. Exogenous vitamin C supplementation significantly inhibited MCP‐1 secretion in U937 monocytes cultured in high‐glucose‐medium. CDNC is a potent hypoglycemic compound with anti‐inflammatory activity apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 and increased IRS‐1 activation in livers of type 2 diabetic rats.</jats:p> Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats Molecular Nutrition & Food Research |
| doi_str_mv |
10.1002/mnfr.200900177 |
| facet_avail |
Online |
| finc_class_facet |
Land- und Forstwirtschaft, Gartenbau, Fischereiwirtschaft, Hauswirtschaft Biologie Technik |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9tbmZyLjIwMDkwMDE3Nw |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9tbmZyLjIwMDkwMDE3Nw |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 |
| imprint |
Wiley, 2010 |
| imprint_str_mv |
Wiley, 2010 |
| issn |
1613-4125 1613-4133 |
| issn_str_mv |
1613-4125 1613-4133 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
jain2010chromiumdinicocysteinatesupplementationcanlowerbloodglucosecrpmcp1icam1creatinineapparentlymediatedbyelevatedbloodvitamincandadiponectinandinhibitionofnfkbaktandglut2inliversofzuckerdiabeticfattyrats |
| publishDateSort |
2010 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Molecular Nutrition & Food Research |
| source_id |
49 |
| title |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_unstemmed |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_full |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_fullStr |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_full_unstemmed |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_short |
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_sort |
chromium dinicocysteinate supplementation can lower blood glucose, crp, mcp‐1, icam‐1, creatinine, apparently mediated by elevated blood vitamin c and adiponectin and inhibition of nfκb, akt, and glut‐2 in livers of zucker diabetic fatty rats |
| topic |
Food Science Biotechnology |
| url |
http://dx.doi.org/10.1002/mnfr.200900177 |
| publishDate |
2010 |
| physical |
1371-1380 |
| description |
<jats:title>Abstract</jats:title><jats:p>Chromium and cysteine supplementation can improve glucose metabolism in animal studies. This study examined the hypothesis that a cysteinate complex of chromium is significantly beneficial than either of them in lowering blood glucose and vascular inflammation markers in Zucker diabetic fatty (ZDF) rats. Starting at the age of 6 wk, ZDF rats were supplemented orally (daily gavages for 8 more weeks) with saline‐placebo (D) or chromium (400 μg Cr/Kg body weight) as chromium dinicocysteinate (CDNC), chromium dinicotinate (CDN) or chromium picolinate (CP) or equimolar <jats:sc>L</jats:sc>‐cysteine (LC, img/Kg body weight), and fed Purina 5008 diet for 8 wk. ZDF rats of 6 wk age before any supplementations and onset of diabetes were considered as baseline. D rats showed elevated levels of fasting blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and oxidative stress (lipid peroxidation) and lower adiponectin and vitamin C, when compared with baseline rats. In comparison to D group, CDNC group had significantly lower blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and lipid peroxidation and increased vitamin C and adiponectin levels. CDN, CP or LC showed significantly less or no effect on these biomarkers. Only CDNC lowered blood creatinine levels in comparison to D. While CDN and CP had no effect, activation of NFκB, Akt and glucose transporter‐2 levels were decreased, insulin receptor substrate 1 (IRS‐1) activation increased in livers of CDNC‐rats. CDNC effect on glycemia, NFκB, Akt and IRS‐1 in liver was significantly greater compared with LC. Blood chromium levels did not differ between Cr‐groups. Exogenous vitamin C supplementation significantly inhibited MCP‐1 secretion in U937 monocytes cultured in high‐glucose‐medium. CDNC is a potent hypoglycemic compound with anti‐inflammatory activity apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 and increased IRS‐1 activation in livers of type 2 diabetic rats.</jats:p> |
| container_issue |
9 |
| container_start_page |
1371 |
| container_title |
Molecular Nutrition & Food Research |
| container_volume |
54 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792341399061921797 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T16:19:17.879Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Chromium+dinicocysteinate+supplementation+can+lower+blood+glucose%2C+CRP%2C+MCP%E2%80%901%2C+ICAM%E2%80%901%2C+creatinine%2C+apparently+mediated+by+elevated+blood+vitamin+C+and+adiponectin+and+inhibition+of+NF%CE%BAB%2C+Akt%2C+and+Glut%E2%80%902+in+livers+of+zucker+diabetic+fatty+rats&rft.date=2010-09-01&genre=article&issn=1613-4133&volume=54&issue=9&spage=1371&epage=1380&pages=1371-1380&jtitle=Molecular+Nutrition+%26+Food+Research&atitle=Chromium+dinicocysteinate+supplementation+can+lower+blood+glucose%2C+CRP%2C+MCP%E2%80%901%2C+ICAM%E2%80%901%2C+creatinine%2C+apparently+mediated+by+elevated+blood+vitamin+C+and+adiponectin+and+inhibition+of+NF%CE%BAB%2C+Akt%2C+and+Glut%E2%80%902+in+livers+of+zucker+diabetic+fatty+rats&aulast=Bull&aufirst=Rebeca&rft_id=info%3Adoi%2F10.1002%2Fmnfr.200900177&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792341399061921797 |
| author | Jain, Sushil K., Croad, Jennifer L., Velusamy, Thirunavukkarasu, Rains, Justin L., Bull, Rebeca |
| author_facet | Jain, Sushil K., Croad, Jennifer L., Velusamy, Thirunavukkarasu, Rains, Justin L., Bull, Rebeca, Jain, Sushil K., Croad, Jennifer L., Velusamy, Thirunavukkarasu, Rains, Justin L., Bull, Rebeca |
| author_sort | jain, sushil k. |
| container_issue | 9 |
| container_start_page | 1371 |
| container_title | Molecular Nutrition & Food Research |
| container_volume | 54 |
| description | <jats:title>Abstract</jats:title><jats:p>Chromium and cysteine supplementation can improve glucose metabolism in animal studies. This study examined the hypothesis that a cysteinate complex of chromium is significantly beneficial than either of them in lowering blood glucose and vascular inflammation markers in Zucker diabetic fatty (ZDF) rats. Starting at the age of 6 wk, ZDF rats were supplemented orally (daily gavages for 8 more weeks) with saline‐placebo (D) or chromium (400 μg Cr/Kg body weight) as chromium dinicocysteinate (CDNC), chromium dinicotinate (CDN) or chromium picolinate (CP) or equimolar <jats:sc>L</jats:sc>‐cysteine (LC, img/Kg body weight), and fed Purina 5008 diet for 8 wk. ZDF rats of 6 wk age before any supplementations and onset of diabetes were considered as baseline. D rats showed elevated levels of fasting blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and oxidative stress (lipid peroxidation) and lower adiponectin and vitamin C, when compared with baseline rats. In comparison to D group, CDNC group had significantly lower blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and lipid peroxidation and increased vitamin C and adiponectin levels. CDN, CP or LC showed significantly less or no effect on these biomarkers. Only CDNC lowered blood creatinine levels in comparison to D. While CDN and CP had no effect, activation of NFκB, Akt and glucose transporter‐2 levels were decreased, insulin receptor substrate 1 (IRS‐1) activation increased in livers of CDNC‐rats. CDNC effect on glycemia, NFκB, Akt and IRS‐1 in liver was significantly greater compared with LC. Blood chromium levels did not differ between Cr‐groups. Exogenous vitamin C supplementation significantly inhibited MCP‐1 secretion in U937 monocytes cultured in high‐glucose‐medium. CDNC is a potent hypoglycemic compound with anti‐inflammatory activity apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 and increased IRS‐1 activation in livers of type 2 diabetic rats.</jats:p> |
| doi_str_mv | 10.1002/mnfr.200900177 |
| facet_avail | Online |
| finc_class_facet | Land- und Forstwirtschaft, Gartenbau, Fischereiwirtschaft, Hauswirtschaft, Biologie, Technik |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9tbmZyLjIwMDkwMDE3Nw |
| imprint | Wiley, 2010 |
| imprint_str_mv | Wiley, 2010 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161 |
| issn | 1613-4125, 1613-4133 |
| issn_str_mv | 1613-4125, 1613-4133 |
| language | English |
| last_indexed | 2024-03-01T16:19:17.879Z |
| match_str | jain2010chromiumdinicocysteinatesupplementationcanlowerbloodglucosecrpmcp1icam1creatinineapparentlymediatedbyelevatedbloodvitamincandadiponectinandinhibitionofnfkbaktandglut2inliversofzuckerdiabeticfattyrats |
| mega_collection | Wiley (CrossRef) |
| physical | 1371-1380 |
| publishDate | 2010 |
| publishDateSort | 2010 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Molecular Nutrition & Food Research |
| source_id | 49 |
| spelling | Jain, Sushil K. Croad, Jennifer L. Velusamy, Thirunavukkarasu Rains, Justin L. Bull, Rebeca 1613-4125 1613-4133 Wiley Food Science Biotechnology http://dx.doi.org/10.1002/mnfr.200900177 <jats:title>Abstract</jats:title><jats:p>Chromium and cysteine supplementation can improve glucose metabolism in animal studies. This study examined the hypothesis that a cysteinate complex of chromium is significantly beneficial than either of them in lowering blood glucose and vascular inflammation markers in Zucker diabetic fatty (ZDF) rats. Starting at the age of 6 wk, ZDF rats were supplemented orally (daily gavages for 8 more weeks) with saline‐placebo (D) or chromium (400 μg Cr/Kg body weight) as chromium dinicocysteinate (CDNC), chromium dinicotinate (CDN) or chromium picolinate (CP) or equimolar <jats:sc>L</jats:sc>‐cysteine (LC, img/Kg body weight), and fed Purina 5008 diet for 8 wk. ZDF rats of 6 wk age before any supplementations and onset of diabetes were considered as baseline. D rats showed elevated levels of fasting blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and oxidative stress (lipid peroxidation) and lower adiponectin and vitamin C, when compared with baseline rats. In comparison to D group, CDNC group had significantly lower blood glucose, HbA<jats:sub>1</jats:sub>, CRP, MCP‐1, ICAM‐1 and lipid peroxidation and increased vitamin C and adiponectin levels. CDN, CP or LC showed significantly less or no effect on these biomarkers. Only CDNC lowered blood creatinine levels in comparison to D. While CDN and CP had no effect, activation of NFκB, Akt and glucose transporter‐2 levels were decreased, insulin receptor substrate 1 (IRS‐1) activation increased in livers of CDNC‐rats. CDNC effect on glycemia, NFκB, Akt and IRS‐1 in liver was significantly greater compared with LC. Blood chromium levels did not differ between Cr‐groups. Exogenous vitamin C supplementation significantly inhibited MCP‐1 secretion in U937 monocytes cultured in high‐glucose‐medium. CDNC is a potent hypoglycemic compound with anti‐inflammatory activity apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 and increased IRS‐1 activation in livers of type 2 diabetic rats.</jats:p> Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats Molecular Nutrition & Food Research |
| spellingShingle | Jain, Sushil K., Croad, Jennifer L., Velusamy, Thirunavukkarasu, Rains, Justin L., Bull, Rebeca, Molecular Nutrition & Food Research, Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats, Food Science, Biotechnology |
| title | Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_full | Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_fullStr | Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_full_unstemmed | Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_short | Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| title_sort | chromium dinicocysteinate supplementation can lower blood glucose, crp, mcp‐1, icam‐1, creatinine, apparently mediated by elevated blood vitamin c and adiponectin and inhibition of nfκb, akt, and glut‐2 in livers of zucker diabetic fatty rats |
| title_unstemmed | Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP‐1, ICAM‐1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut‐2 in livers of zucker diabetic fatty rats |
| topic | Food Science, Biotechnology |
| url | http://dx.doi.org/10.1002/mnfr.200900177 |